A fully percutaneous bypass system using the femoral vein as a conduit was safe and effective in patients with long superficial femoral artery lesions at 12 months, according to new data from the ...

The DETOUR procedure creates a pathway that originates in the SFA, travels through the femoral vein and ends in the popliteal artery, bypassing the diseased part of the artery.

PQ Bypass, Inc. is a Silicon Valley-based medical device company working to transform the treatment of long-segment peripheral artery disease with minimally-invasive endovascular solutions.

Learn about the benefits of femoral endarterectomy and what the procedure can treat. This article also looks at preparation, possible risks, and more.

One-year results of the DETOUR2 trial published in the Journal of Vascular Surgery demonstrate outstanding results for Endologix LLC’s percutaneous transmural arterial bypass system for treatment of ...

Endovascular Femoral Artery Bypass: First-in-Man Experience with a Novel, Percutaneous Approach to TASC D Lesions ...

Compared with endovascular therapy, thromboendarterectomy surgery was associated with better 1-year patency, but longer hospital stays, in patients undergoing revascularization for common femoral ...

If you have peripheral artery disease (PAD), bypass surgery can help. Learn more about PAD, bypass surgery, and the risks and recovery process of this treatment.